标题
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 23, Pages 7153-7158
出版商
Proceedings of the National Academy of Sciences
发表日期
2015-05-27
DOI
10.1073/pnas.1507719112
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies
- (2014) B. Ayoglu et al. EMBO Molecular Medicine
- Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients
- (2014) Yetrib Hathout et al. HUMAN MOLECULAR GENETICS
- Crystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid Ligand
- (2014) Amy D. Gelinas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor
- (2014) Shashi Gupta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biomarkers and surrogate endpoints in Duchenne: Meeting report
- (2014) Annemieke Aartsma-Rus et al. NEUROMUSCULAR DISORDERS
- A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy
- (2014) Jean K. Mah et al. NEUROMUSCULAR DISORDERS
- Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse
- (2014) Jinhyun Kim et al. ARTHRITIS RESEARCH & THERAPY
- Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents
- (2014) John C Rohloff et al. Molecular Therapy-Nucleic Acids
- Therapeutic advances in muscular dystrophy
- (2013) Doris G. Leung et al. ANNALS OF NEUROLOGY
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
- (2013) Francesco S. Loffredo et al. CELL
- VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects
- (2013) Christopher R. Heier et al. EMBO Molecular Medicine
- New developments in the use of gene therapy to treat Duchenne muscular dystrophy
- (2013) Susan Jarmin et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The cooperative international neuromuscular research group duchenne natural history study-a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used
- (2013) Craig M. McDonald et al. MUSCLE & NERVE
- THE 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study
- (2013) Craig M. Mcdonald et al. MUSCLE & NERVE
- The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and othe
- (2013) Erik K. Henricson et al. MUSCLE & NERVE
- Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
- (2013) Rebecca J. Fairclough et al. NATURE REVIEWS GENETICS
- Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2
- (2013) Y.-S. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders
- (2013) Rosamund C. Smith et al. Current Opinion in Supportive and Palliative Care
- Ataluren as an Agent for Therapeutic Nonsense Suppression
- (2012) Stuart W. Peltz et al. Annual Review of Medicine
- Novel Approaches to Corticosteroid Treatment in Duchenne Muscular Dystrophy
- (2012) Eric P. Hoffman et al. Physical Medicine and Rehabilitation Clinics of North America
- Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets
- (2012) D. R. Davies et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Advances in human proteomics at high scale with the SOMAscan proteomics platform
- (2011) Larry Gold et al. New Biotechnology
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
- (2011) Larry Gold et al. PLoS One
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice
- (2010) Kevin J. Morine et al. PLoS One
- The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum
- (2009) N. L. Anderson CLINICAL CHEMISTRY
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
- (2009) Katharine Bushby et al. LANCET NEUROLOGY
- The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy
- (2009) Craig M. McDonald et al. MUSCLE & NERVE
- Myostatin Propeptide Gene Delivery by Adeno-Associated Virus Serotype 8 Vectors Enhances Muscle Growth and Ameliorates Dystrophic Phenotypes in mdx Mice
- (2008) Chunping Qiao et al. HUMAN GENE THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started